Clinical trials
Phase 3 Gastrointestinal Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 4 |
| Terminated | 4 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 3 |
| Pfizer | 2 |
| Amgen | 1 |
| Anthos Therapeutics, Inc. | 1 |
| AstraZeneca | 1 |
| GlaxoSmithKline | 1 |
| NRG Oncology | 1 |
| National Cancer Institute (NCI) | 1 |
| Sumitomo Pharma America, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gastrointestinal Neoplasms | 12 |
| Colorectal Neoplasms | 4 |
| Colonic Diseases | 3 |
| Digestive System Diseases | 3 |
| Digestive System Neoplasms | 3 |
| Gastrointestinal Diseases | 3 |
| Intestinal Diseases | 3 |
| Intestinal Neoplasms | 3 |
| Rectal Diseases | 3 |
| Breast Neoplasms | 2 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.